Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 20/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7074834 | 0.87 | SIGMAR1 (1.00) | SIGMAR1 | |
| SCHEMBL7206334 | 0.86 | SIGMAR1 (0.73) | SIGMAR1 | |
| Hydrochloric Acid SCHEMBL7206406 | 0.86 | SIGMAR1 (1.00) | SIGMAR1 | |
| SCHEMBL6728380 | 0.85 | SIGMAR1 (0.59) | SIGMAR1 | |
| SCHEMBL6727820 | 0.84 | SIGMAR1 (1.00) | SIGMAR1 | |
| SCHEMBL7073999 | 0.84 | SIGMAR1 (0.71) | SIGMAR1 | |
| Hydrochloric Acid SCHEMBL7201782 | 0.83 | SIGMAR1 (1.00) | SIGMAR1 | |
| SCHEMBL7201862 | 0.83 | SIGMAR1 (0.83) | SIGMAR1 | |
| SCHEMBL6719624 | 0.80 | SIGMAR1 (0.51) | SIGMAR1 | |
| SCHEMBL6720933 | 0.80 | SIGMAR1 (0.77) | SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0705100-B1 | THERAPEUTIC SUBSTITUTED GUANIDINES | CENES LTD (GB) | 2003-07-30 | — | — | EP | disclosed |
| US-6156741-A | Therapeutic substituted guanidines | CAMBRIDGE NEUROSCIENCE, INC. (US) | 2000-12-05 | — | — | US | disclosed |
| US-6153604-A | Therapeutic substituted guanidines | CAMBRIDGE NEUROSCIENCE, INC. (US) | 2000-11-28 | — | — | US | disclosed |
| US-6147063-A | NEUROTOXICITY | CAMBRIDGE NEUROSCIENCE, INC. (US) | 2000-11-14 | — | — | US | disclosed |
| EP-0705100-A4 | THERAPEUTIC SUBSTITUTED GUANIDINES | CAMBRIDGE NEUROSCIENCE INC (US) | 1996-05-29 | — | — | EP | disclosed |
| EP-0705100-A1 | THERAPEUTIC SUBSTITUTED GUANIDINES | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1996-04-10 | — | — | EP | disclosed |
| WO-1994027591-A1 | THERAPEUTIC SUBSTITUTED GUANIDINES | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1994-12-08 | — | — | WO | disclosed |